Literature DB >> 18712568

Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.

Massimo Falconi1, Stefano Crippa, Ismael Domínguez, Giuliano Barugola, Paola Capelli, Stefano Marcucci, Stefania Beghelli, Aldo Scarpa, Claudio Bassi, Paolo Pederzoli.   

Abstract

BACKGROUND: Nodal metastasis is considered a major prognostic factor in patients with ampulla of Vater carcinoma (AVC). No study has investigated the significance of the ratio between metastatic and resected/examined lymph nodes (LNR) in patients with AVC.
METHODS: Demographic, operative, and pathology data, including number of resected/evaluated nodes and LNR, were collected from patients who underwent pancreaticoduodenectomy with radical intent for invasive AVC from 1990 to 2005. Survival rates and recurrence patterns were evaluated and predictors were identified.
RESULTS: In 90 evaluable patients (51 males, 39 females, median age 62.5 years), 5-year disease-specific survival (DSS) was 61%. The median number of resected/evaluated nodes was 16 (range: 5-47); 50% of the patients had nodal metastases. The 5-year DSS according to LNR was 75%, 49%, 38%, and 0% for LNR = 0, LNR >0 and < or =0.2, LNR >0.2, and < or =0.4, and LNR >0.4 (P = 0.002), respectively. The 5-year DSS was 81% in patients with >16 resected/evaluated nodes compared with 45% in those with < or =16 resected/evaluated nodes (P = 0.001). On multivariate analysis LNR and a number of resected/evaluated nodes >16 were significant predictors of survival; a number of resected/evaluated nodes >16 was also the only independent predictor of recurrence.
CONCLUSIONS: After curative resection for AVC, LNR and a cutoff of 16 resected/evaluated nodes are powerful prognostic factors. LNR might represent a major parameter for patient stratification in adjuvant treatment trials.

Entities:  

Mesh:

Year:  2008        PMID: 18712568     DOI: 10.1245/s10434-008-0099-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  39 in total

1.  Prognostic value of the lymph node ratio after resection of periampullary carcinomas.

Authors:  Shahid G Farid; Gavin A Falk; Daniel Joyce; Sricharan Chalikonda; R Matthew Walsh; Andrew M Smith; Gareth Morris-Stiff
Journal:  HPB (Oxford)       Date:  2012-11-19       Impact factor: 3.647

2.  Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.

Authors:  Jian-Wei Zhang; Yun-Mian Chu; Zhong-Min Lan; Xiao-Long Tang; Ying-Tai Chen; Cheng-Feng Wang; Xu Che
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

Review 3.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

4.  Lymph node retrieval in pancreaticoduodenectomy specimens: does educating the pathologist matter?

Authors:  D Rohan Jeyarajah; Amit Khithani; Veeraiah Siripurapu; Elizabeth Liu; Ashley Thomas; A Joe Saad
Journal:  HPB (Oxford)       Date:  2013-05-15       Impact factor: 3.647

Review 5.  Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.

Authors:  María Del Carmen Gómez-Mateo; Luis Sabater-Ortí; Antonio Ferrández-Izquierdo
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

6.  Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.

Authors:  Serdar Balci; Olca Basturk; Burcu Saka; Pelin Bagci; Lauren M Postlewait; Takuma Tajiri; Kee-Taek Jang; Nobuyuki Ohike; Grace E Kim; Alyssa Krasinskas; Hyejeong Choi; Juan M Sarmiento; David A Kooby; Bassel F El-Rayes; Jessica H Knight; Michael Goodman; Gizem Akkas; Michelle D Reid; Shishir K Maithel; Volkan Adsay
Journal:  Ann Surg Oncol       Date:  2015-03-18       Impact factor: 5.344

7.  Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.

Authors:  Ibrahim Nassour; Alana Christie; Michael A Choti; John C Mansour; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; Matthew R Porembka; Xian-Jin Xie; Sam C Wang
Journal:  J Gastrointest Surg       Date:  2018-03-15       Impact factor: 3.452

8.  N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma.

Authors:  Nakul P Valsangkar; Devon M Bush; James S Michaelson; Cristina R Ferrone; Jennifer A Wargo; Keith D Lillemoe; Carlos Fernández-del Castillo; Andrew L Warshaw; Sarah P Thayer
Journal:  J Gastrointest Surg       Date:  2012-12-11       Impact factor: 3.452

Review 9.  Review of the investigation and surgical management of resectable ampullary adenocarcinoma.

Authors:  James Askew; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

10.  2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.

Authors:  Jin He; Nita Ahuja; Martin A Makary; John L Cameron; Frederic E Eckhauser; Michael A Choti; Ralph H Hruban; Timothy M Pawlik; Christopher L Wolfgang
Journal:  HPB (Oxford)       Date:  2013-03-08       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.